BioMed Realty Trust, Inc. (BMR) Reports In-Line Q2 FFO, Revenues Top Slightly
Tweet
Share
E-mailGet Alerts BMR Hot Sheet
Price: $1.29 +1.57%
Financial Fact:
Net income/loss attributable to noncontrolling interests: -4.16M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Net income/loss attributable to noncontrolling interests: -4.16M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
BioMed Realty Trust, Inc. (NYSE: BMR) reported Q2 FFO of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $106.8 million versus the consensus estimate of $105.56 million.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
BioMed Realty Trust, Inc. sees FY2011 FFO of $1.16-$1.20, versus the consensus of $1.18.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Beamr Launches ML-Safe Lossless Compression for Autonomous Vehicle Fleets
- Fluence Energy cuts fiscal 2026 revenue outlook on supply chain woes
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
